Company Overview
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Company Information
- CEO
- Robert M. Davis
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 73000
Contact Information
- Website
- https://www.merck.com
- Address
- 2000 Galloping Hill Road
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 210.22B market capitalization
- Trading Volume: 4.29M shares traded today
- Price Range: 52-week range of $73.31 - $120.30
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Merck & Co., Inc.
Merck & Co., Inc. (MRK) operates in the Drug Manufacturers - General industry within the Healthcare sector. With a current market capitalization of 210.22B, the company represents a significant player in its market. The stock is currently trading at $84.16 with a negativedaily change of 0.05%.
The company's 73000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 12.97, beta of 0.39, and 52-week price range from $73.31 to $120.30when evaluating investment opportunities.
Why Invest in Merck & Co., Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Robert M. Davis
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.